TGFB1 and cancer: Inhibition of the MAPK and TGF-β pathways has been found to prevent EMT triggered by HIV-1 in oral epithelial cells, potentially leading to new treatment methods for cancers linked to HIV/HPV coinfection (Tugizov, 2016).